-
2018 Parkinson's Advocacy Awards Presented to Community Leaders
March 30, 2018
… with Parkinson's in 1987 and passed away of complications from the disease in 2004. Leslie Peters, Colorado Leslie … with Parkinson's in 1980 and died of complications from the disease in 1998. Francis Collins, MD, PhD, Director … a new program area focused on Parkinson's disease. From 1993 to 2008, Dr. Collins served as Director of the …
-
Treatments for ''Off'' Time
… benefits and side effects. Learn more about both procedures from Rachel Dolhun, MD, DipABLM, a movement disorder … by late 2025. This resource was brought to you with support from Amneal Pharmaceuticals and Merz Therapeutics. Partner … The Michael J. Fox Foundation has a policy of refraining from advocating or endorsing any drug therapy, course of …
-
What We Fund: $67 Million for PD Diagnostics and Treatment Pipeline
October 31, 2025
… and September 2025. These grants cover themes ranging from clearer Parkinson’s disease definitions and advances in … treatments are working. Catalyzed Communities Funding from MJFF also brings together researchers, clinicians and … and make up a portion of funded research, which extends from individually selected projects to large studies and …
-
2026 Parkinson's Unity Walk
… at the Bandshell Plaza, watch programming at the Bandshell from PD groups, explore informational booths featuring … research and policy with an additional $1.2 million match from a generous, anonymous donor. All of this culminated in … compiled a comprehensive list of the questions we hear from our community which can be viewed HERE . If you do not …
-
2025 Parkinson's Disease Therapeutics Conference
… 300 research and business development professionals from both academia and industry and showcases the most exciting and innovative research from MJFF's research portfolio. Novel advances in basic and translational research from both academic and industry labs are highlighted through …
-
The New York Times: A Decade Later, Genetic Map Yields Few New Cures
June 12, 2010
… that the associations are spurious. Many of them may “stem from factors other than a true association with disease … feasible because the cost of sequencing has plummeted, from about $500 million for the first human genome completed … the DNA of the genome and controls access to it. The data from the HapMap has also enabled population geneticists to …